Two new oral contraceptives are hitting the market

Two new oral contraceptives are hitting the market...Cyclessa from Organon and Yasmin from Berlex.

Cyclessa is a new low-dose triphasic oral contraceptive. It contains less estrogen than Tri-Cyclen and other triphasic pills.

Cyclessa tablets contain 25 mcg/day of ethinyl 0.1, 0.125, and 0.15 mg/day of desogestrel in each phase.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote